185 related articles for article (PubMed ID: 6169263)
1. In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.
Welton AF; Hope WC; Crowley HJ; Salvador RA
Agents Actions; 1981 Jul; 11(4):345-51. PubMed ID: 6169263
[TBL] [Abstract][Full Text] [Related]
2. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
Goto K; Hisadome M; Terasawa M
Int Arch Allergy Appl Immunol; 1982; 68(4):332-7. PubMed ID: 6178699
[TBL] [Abstract][Full Text] [Related]
4. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
Yanagihara Y; Kasai H; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
[TBL] [Abstract][Full Text] [Related]
7. Enigma of disodium cromoglycate action on mast cells.
Krüger PG; Bloom GD
Int Arch Allergy Appl Immunol; 1979; 60(1):110-4. PubMed ID: 88418
[TBL] [Abstract][Full Text] [Related]
8. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological profile and initial clinical evaluation of tiacrilast (Ro 22-3747): a new antiallergic agent.
Welton AF; Dunton AW; McGhee B
Agents Actions; 1986 Jun; 18(3-4):313-7. PubMed ID: 2428219
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of nifedipine and cromolyn sodium on skin reactions and 45Ca uptake and histamine release in rat mast cells induced by various stimulating agents.
Tanizaki Y; Akagi K; Lee KN; Townley RG
Int Arch Allergy Appl Immunol; 1983; 72(2):102-9. PubMed ID: 6192096
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
[TBL] [Abstract][Full Text] [Related]
12. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
Khandwala A; Coutts SM; Weinryb I
Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
[TBL] [Abstract][Full Text] [Related]
13. Antiallergic activity of tiaramide (RHC 2592-A).
Khandwala A; Coutts S; Weinryb I
Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
[TBL] [Abstract][Full Text] [Related]
16. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I
Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075
[TBL] [Abstract][Full Text] [Related]
17. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
18. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue.
Hashimoto T; Kohno SW; Ohata K; Yanagihara Y; Shida T
Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036
[TBL] [Abstract][Full Text] [Related]
19. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro.
Sharpe TJ; Ross JW; Spicer BA
Agents Actions; 1978 Apr; 8(3):199-202. PubMed ID: 78665
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
González RG; García M; Pérez Saad H; de la Vega AR
Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
